Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children with cancer aged 4–10 who are scheduled for intrathecal chemotherapy will receive virtual reality (VR) glasses immediately before the procedure while a control group receives no distraction intervention. Researchers will measure self- or observer-rated fear and anxiety and record physiological parameters (heart rate, blood pressure, respiratory rate, and oxygen saturation) before and during the procedure. The study uses VR as a non-pharmacological distraction tool to alter sensory input and focus attention away from the procedure. Outcomes in the VR group will be compared to the control group to determine short-term effects on emotional and physiological stress.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. outside the 4-10 age range,
2. have a chronic or genetic illness,
3. have an intellectual, visual, or hearing impairment,
4. cannot adapt to virtual reality glasses,
5. are uncooperative (both themselves and their parents),
6. neither they nor their parents are willing to participate in the research and have not given their verbal or written consent will not be included in the study.

Exclusion Criteria:

1. outside the 4-10 age range,
2. have a chronic or genetic illness,
3. have an intellectual, visual, or hearing impairment,
4. cannot adapt to virtual reality glasses,
5. are uncooperative (both themselves and their parents),
6. neither they nor their parents are willing to participate in the research and have not given their verbal or written consent will not be included in the study.

Where it's running

• Erciyes University
  Kayseri, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Eda Kalaycı
• Email: eda_kalayci937@hotmail.com
• Phone: +905349538932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FaceSay: a computer program to help kids recognize facial expressions and improve social interactions

  A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT07923370

• Access to Innovative Cancer Treatments for Children and Young People in Belgium

  This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Antwerp and 5 other locations · NCT07727694

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes

  This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.

  Recruiting Resonance, Inc. · Yerevan and 5 other locations · NCT07632014

• Laser thermal therapy for young people with low-grade glioma

  This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07506239

• Thyroid cancer risk and follow-up after childhood radiotherapy

  This project will test whether earlier and regular ultrasound plus genetic testing can detect thyroid nodules and cancers sooner in children treated with radiotherapy.

  Recruiting at 2 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna and 1 other locations · NCT07473518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.